Loading…
← CockpitCompetitor Analysis › 688800.SS Suzhou Recodeal Interconnect System Co., Ltd. Class AOpen in the cockpit ↗

Suzhou Recodeal Interconnect System Co., Ltd. Class A688800.SSCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Commercial Services

Chinese maker of interconnect systems (connectors/wiring) likely for EV batteries or electronics.

Momentum laggard 0
Mkt cap
$1.26B
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$58.7M
20-day average traded
Fwd P/E
31.0×
forward earnings
ROIC−WACC
-2.1 pp
WACC 12.4%
Hurdle
-16 pp
Req g minus delivered
Next earnings
154 days
21 Apr 2027
Close · CNYCN¥30.00
1D+0.6%
1W-17.9%
1M-34.0%
3M-51.4%
6M-68.1%
YTD-49.4%
1Y-43.5%
ATR %9.9%
52w lowhigh71.6% off high

What Suzhou Recodeal Interconnect System does

Chinese maker of interconnect systems (connectors/wiring) likely for EV batteries or electronics.

Products and services

  • Interconnect/connector systems

Customers

  • EV battery/electronics makers

Where it sits in the supply chain

  • Electronics
  • Interconnect systems
  • Connectors/wiring for EV/electronics

What could go right

  • EV battery pack production growth

What could go wrong

  • Customer concentration

Moat: none

Headquarters: Suzhou, China · Employees: 2,380

Suzhou Recodeal Interconnect System at a glance

Size Suzhou Recodeal Interconnect System (688800.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.26B, the 1768th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥30.00 on 18 Nov 2026.

Performance Over six months the shares fell 68.1%, against -17.4% for the median peer and -20.0% for the China market (cap-weighted) — lowest of 21 in its peer set.

Growth Revenue grew 5.0% over the last twelve months (peer median +10.0%); the operating margin is 8.7% (peer median 10.5%).

Valuation It trades at 31.0× forward earnings against a peer median of 28.6× (9th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 23% a year for seven years (Req g). Recent delivered growth is +39%, so the hurdle is -16 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.1 points below its cost of capital (12.4% WACC).

Next results Next results expected around 21 Apr 2027 (exchange calendar; dates can move).

Relative performance

25507510021 May 202621 Aug 202618 Nov 2026Peer median 82688800.SS 29
Six months, rebased to 100: Suzhou Recodeal Interconnect System against the median of its 20 peers (local-currency closes).

Suzhou Recodeal Interconnect System financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥3.30BCN¥3.14BCN¥2.41BCN¥1.55BCN¥1.62B
Revenue growth—+30%+56%-4%—
Gross profitCN¥763MCN¥655MCN¥499MCN¥366MCN¥430M
EBITDAn/aCN¥455MCN¥280MCN¥171MCN¥286M
Net incomeCN¥217MCN¥299MCN¥175MCN¥137MCN¥253M
Free cash flowCN¥272M-CN¥77.1M-CN¥217M-CN¥299M-CN¥110M
Capital expenditureCN¥286MCN¥288MCN¥291MCN¥485MCN¥229M
Total debtCN¥2.32BCN¥2.11BCN¥1.03BCN¥675MCN¥394M

Quarterly statements and history in the cockpit →

Suzhou Recodeal Interconnect System competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%-20%0%+20%CONCORDBIO68835197466881126031120023386006546881282384CRAI1515300725DBGRHLDCLVTCMPDI688252688202301413002607688800.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Suzhou Recodeal Interconnect System is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×200×400×CONCORDBIO68835197466881126031120023382384CRAI300725DBGCLVT688202301413002607688800.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Suzhou Recodeal Interconnect System is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%+60%-25%0%25%50%CONCORDBIO6883519746688112603112600654688128CRAI300725DBGCLVTCMPDI688252002607688800.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Suzhou Recodeal Interconnect System is the large dot.

Suzhou Recodeal Interconnect System competitors and peer comparison

How Suzhou Recodeal Interconnect System compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Suzhou Recodeal Interconnect System against its 20 peers (data as of 18 Nov 2026)
Measure688800.SSPeer medianRank in peer set
1-month return-34.0%-2.3%2nd lowest of 21
6-month return-68.1%-17.4%lowest of 21
Distance from 52-week high-71.6%-36.8%lowest of 21
Revenue growth (TTM)+5.0%+10.0%7th lowest of 21
Operating margin8.7%10.5%10th lowest of 21
Forward P/E31.0×28.6×9th cheapest of 17
Growth the price implies (Req g, 7 yrs)22.7%12.6%6th most demanding of 17
Growth delivered (Del g)+38.9%+13.8%highest of 16
Hurdle (Req g minus delivered)-16.2 pp-1.1 pp3rd least demanding of 16
ROIC minus cost of capital-2.1 pp-1.5 pp11th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Suzhou Recodeal Interconnect System 688800.SSChina$1.26B-68%+5%9%31.0×22.7%+38.9%
Concord Biotech CONCORDBIO.NSIndia$1.26B-2%+4%28%33.9×44.4%+11.6%
Shanghai MicroPort EP Medtech 688351.SSChina$1.31B-30%+20%3%137.1×42.5%+26.7%
TKC 9746.TJapan$1.31B+22%+5%20%19.1×-10.1%+5.7%
Siglent Technologies 688112.SSChina$1.19B-26%+30%24%39.2×27.7%+22.0%
Shanxi Huaxiang 603112.SSChina$1.19B-33%+9%11%11.6×0.9%+16.2%
Changchun Up Optotech 002338.SZChina$1.34B-41%+22%2%43.1×n/an/a
China Security 600654.SSChina$1.34B-31%-30%-1%n/a56.0%+0.4%
China National Electric Apparatus Research Institute 688128.SSChina$1.35B-17%+8%11%14.7×3.2%+13.5%
SBS 2384.TJapan$1.35B+26%+17%5%13.9×-4.7%+13.8%
CRA International CRAIUnited States$1.35B+46%+13%10%23.3×6.6%+8.1%
Nittetsu Mining 1515.TJapan$1.17B-3%+18%8%n/an/an/a
PharmaBlock Sciences (Nanjing) 300725.SZChina$1.36B+5%+11%11%37.5×24.2%+14.1%
Derichebourg DBG.PAFrance$1.37B-18%-3%5%8.8×6.7%+6.3%
Resolute Holdings Management RHLDUnited States$1.16B+34%+10%12%n/a16.6%n/a
Clarivate CLVTUnited States$1.38B-12%-9%8%3.5×13.2%+14.4%
Central Mine Planning & Design Institute CMPDI.NSIndia$1.38B-22%+10%33%n/a4.5%+18.7%
Jadard Technology 688252.SSChina$1.14B-22%+6%12%22.3×12.0%+31.3%
Shanghai Medicilon 688202.SSChina$1.39B+8%+42%-2%85.1×n/an/a
Shenzhen Ampron Technology 301413.SZChina$1.40B-28%+11%2%387.2×n/an/a
Offcn Education Technology 002607.SZChina$1.40B-40%-2%13%34.7×15.7%-27.6%

Questions

Which companies are Suzhou Recodeal Interconnect System's closest peers?
The cockpit's peer set: Concord Biotech (CONCORDBIO.NS), Shanghai MicroPort EP Medtech (688351.SS), TKC (9746.T), Siglent Technologies (688112.SS), Shanxi Huaxiang (603112.SS), Changchun Up Optotech (002338.SZ), China Security (600654.SS), China National Electric Apparatus Research Institute (688128.SS).
Is Suzhou Recodeal Interconnect System expensive compared with its peers?
On forward p/e it trades at 31.0× against a peer median of 28.6×, 9th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 23% a year for seven years (Req g). Recent delivered growth is +39%, so the hurdle is -16 pp: the price already allows for a slowdown.
How has Suzhou Recodeal Interconnect System stock performed?
Over six months to 18 Nov 2026 the shares returned -68.1% against -17.4% for the median peer; over one year -43.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.